Express News | Perceptive Advisors LLC - Had Previously Reported 5.8% Stake in VBI Vaccines as of Nov 17, 2023
Moomoo 24/7Apr 17 16:29 ET
Express News | Perceptive Advisors LLC Reports 4.4% Stake in VBI Vaccines as of April 16 - SEC Filing
Moomoo 24/7Apr 17 16:28 ET
Express News | VBI Vaccines Inc : Raymond James Cuts Target Price to $5 From $6
Moomoo 24/7Apr 17 07:20 ET
VBI Vaccines FY Non-GAAP EPS of $3.96
Seeking AlphaApr 16 11:53 ET
VBI Vaccines Soars With Hepatitis B Vaccine Success
TipRanksApr 16 08:49 ET
VBI Vaccines 2023 Rev $8.7M >VBIV
VBI Vaccines 2023 Rev $8.7M >VBIV
Dow JonesApr 16 08:01 ET
Express News | VBI Vaccines Reports Full Year 2023 Financial Results
Moomoo 24/7Apr 16 08:00 ET
VBI Vaccines Raises $1.7 Million in Direct Share Offering
TipRanksApr 11 16:24 ET
Express News | VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Moomoo 24/7Apr 11 16:05 ET
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Fastenal Company (NASDAQ:FAST) fell sharply during Thursday's session following worse-than-expected first-quarter financial results. Fastenal reported first-quarter FY24 sales growth of 1.9
BenzingaApr 11 13:33 ET
Express News | VBI Vaccines Shares Are Trading Lower After the Company Announced a $2 Million Registered Direct Offering at $0.88 per Share
Moomoo 24/7Apr 9 15:55 ET
Express News | VBI Vaccines Announces $2M Registered Direct Offering At $0.88/Share
Moomoo 24/7Apr 9 14:48 ET
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that it has entered into definitive agreements for
BusinesswireApr 9 14:45 ET
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Shares of Biophytis S.A. (NASDAQ:BPTS) rose sharply in today's pre-market trading after reporting FY23 results. Biophytis posted a FY23 loss of €0.03 per share, versus a year-ago loss of €0.14 per s
BenzingaApr 9 06:05 ET
VBI Vaccines Inc Release: Content Unintelligible
TipRanksApr 3 08:39 ET
VBI Vaccines to Present Early Phase 2b Cancer Vaccine Results
TipRanksApr 3 08:12 ET
Express News | VBI Vaccines Presents Early Tumor Response Data From Randomized Controlled Phase 2b Study Of VBI-1901 In Recurrent Glioblastoma; Early Data From Patients Eligible For Evaluation At Week 12 Show Two Observations Of Stable Disease, Indicating No Tumor Progr
Moomoo 24/7Apr 3 08:07 ET
VBI Vaccines Bolsters Collaboration With Canadian Government
TipRanksApr 2 08:12 ET
Express News | VBI Vaccines Expands Collaboration With Canadian Government; Says Under The New Agreement, The Remaining C$28M Of Funding Available Under The Previously Committed C$56M Will Be Directed Toward The Development Of VBI's MLE Platform
Moomoo 24/7Apr 2 08:09 ET
Express News | VBI Vaccines To Expand Strategic Partnership With Canadian Government; Partnership To Direct CAD$28M Of Funding Remaining Under Original CAD$56M Award To Continue Development Of Proprietary Tech Platforms
Moomoo 24/7Apr 2 08:08 ET
No Data
No Data